Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02552 HUA MEDICINE-B
RT Nominal up4.320 +0.320 (+8.000%)
Ranking Overview
Buy
Ranking based on 2 research report(s)
Average Ranking 2.00
0
2
0
0
0
Previous Financial Performance
Financial Year 12/2024 EPS -25.00 RMB (cts)
Net Profit -250.14 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2025835.4779.50--850.94820.00
2026-37.69-3.50---31.37-44.00
202759.975.50--99.0020.93
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2025850.9481.00--GUOYUAN SECBuy6.50 17/09/2025
2025820.0078.00--CITIC SECBuy5.50 12/09/2025
 
2026-31.37-3.00--GUOYUAN SEC----17/09/2025
2026-44.00-4.00--CITIC SEC----12/09/2025
 
202720.932.00--GUOYUAN SEC----17/09/2025
202799.009.00--CITIC SEC----12/09/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 30/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service